KHDRBS1 and neoplasm: In vivo, xenograft models showed that both tumor volume (Figure 4J,K) and weight (Figure 4L) were obviously reduced after sunitinib treatment for 4 weeks in the control group, while the tumor volume and weight were reduced slightly because of a reduction in Sam68 expression in tumor cells.